Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

The Power Of The Open Public Hearing

May 22 2023

• By Michael McCaughan

FDA open public hearing — • Source: Nielsen Hobbs; the Pink Sheet | Shutterstock, Getty images

Related Content

When History Has Its Eyes On You: Opill Vote Puts US FDA In Tough Spot

May 15 2023

FDA Panel Takes ‘Leap Of Faith’ In Backing Epinephrine Nasal Spray For Anaphylaxis

May 12 2023

Slim Adcomm Majority Boosts Sarepta’s Gene Therapy In Duchenne Muscular Dystrophy

May 13 2023

Ahead Of Sarepta Advisory Committee, FDA Feels Congressional Pressure About Public Participation

May 08 2023

FDA May Ask HRA For Another OTC Birth Control Actual Use Study Due To ‘Improbable Dosing’

May 08 2023

Related Companies

Perrigo Company PLC

ARS Pharmaceuticals, Inc.

Sarepta Therapeutics, Inc.

Additional Topics

United States Advisory Committees Drug Review Drug Approval Standards Regulation BioPharmaceutical

More from US FDA Performance Tracker

More from Regulatory Trackers

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window